A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl [corrected] choline], shows superior safety and simil

scientific article published on 8 June 2006

A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl [corrected] choline], shows superior safety and simil is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1124/JPET.106.103184
P698PubMed publication ID16763096

P2093author name stringLee JY
Hoffman A
Dahan A
Kozak A
Shapiro I
Rosenberg G
Raz S
Friedman JE
Koh JY
Younis F
Duvdevani R
Dvir E
Angel I
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)1248-1256
P577publication date2006-06-08
P1433published inJournal of Pharmacology and Experimental TherapeuticsQ1500272
P1476titleA novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl [corrected] choline], shows superior safety and simil
P478volume318